Table 1 Donor demographics
Staff | Resident | Total | % of total | |
|---|---|---|---|---|
Total third vaccine participants (n) | 183 | 158 | 341 | 100 |
Age ≥80 years | 0 | 107 (69+) | 107 (69+) | 31 (65+) |
Age 65–79 years | 8 (5+) | 43 (27+) | 51 (32+) | 15 (62.7+) |
Age ≤64 years | 175 (94+) | 8 (3+) | 183 (97+) | 54 (53+) |
Median age in years (IQR) | 48(40–58) | 84(76–92) | 63(48–85) | |
Female | 164 (91+) | 103 (69+) | 267 (160+) | 78.3 (60+) |
Male | 19 (8+) | 55 (30+) | 74 (38+) | 21.7 (51+) |
Baseline mRNA vaccine recipients | 99 (52+) | 64 (46+) | 163 (98+) | 47.8 (60.1+) |
Baseline ChAdOx1 recipients | 84 (47+) | 94 (53+) | 178 (100+) | 52.2 (56.2+) |
Median days between third vaccine and sample (IQR) | 93 (38–113) | 77 (25–113) | 92 (31–113) | |
Total LTCFs | 48 | |||
Mean participants/LTCF (s.d.) | 7.1 (5.1) |
